A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Two Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Leuprorelin (Primary)
- Indications Endometriosis
- Focus Pharmacodynamics
- Sponsors Enteris BioPharma
- 24 Aug 2017 According to an Enteris BioPharma media release, first patient has been dosed.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 09 Jun 2017 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.